← Product Code [IYE](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IYE) · K103394 # BARCODE CONICAL COLLIMATOR VERIFICATION (BCCV) (K103394) _Varian Medical Systems, Oncology Systems · IYE · Jan 12, 2011 · Radiology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IYE/K103394 ## Device Facts - **Applicant:** Varian Medical Systems, Oncology Systems - **Product Code:** [IYE](/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IYE.md) - **Decision Date:** Jan 12, 2011 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 892.5050 - **Device Class:** Class 2 - **Review Panel:** Radiology ## Indications for Use The Barcode Conical Collimator Verification device assists operators of radiation therapy devices by preventing irradiation until the conical collimator required by the treatment plan is in place. ## Device Story BCCV device provides verification of conical collimators for Varian High Energy Clinac and TrueBeam radiation therapy systems. Device uses barcode scanning to confirm that the specific conical collimator attached to the system matches the requirements of the patient's treatment plan. Operates by preventing irradiation until the correct collimator is scanned and verified. Used in clinical radiation therapy settings by radiation therapists/physicians. Ensures correct hardware configuration for stereotactic radiosurgery (SRS) treatments; prevents potential delivery errors due to incorrect collimator selection; enhances patient safety by enforcing treatment plan compliance. ## Clinical Evidence Bench testing only. ## Technological Characteristics Barcode scanning system for hardware verification. Integrates with Varian High Energy Clinac and TrueBeam radiation therapy systems. Operates as a safety interlock to prevent beam delivery based on hardware configuration status. ## Regulatory Identification A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories. ## Predicate Devices - 4D Integrated Treatment Console with PAVS ([K081036](/device/K081036.md)) ## Reference Devices - Varian High Energy Clinac ([K100890](/device/K100890.md)) - TrueBeam ([K092871](/device/K092871.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ ## KID3394 ## Premarket Notification 510(k) Summary Barcode Conical Collimator Verification (BCCV) JAN 1 2 2011 The following information is provided following the format of 21 CFR 807.92. | Submitter's Name: | Varian Medical Systems, Inc.
3100 Hansen Way e-110
Palo Alto, CA 94304 | |-----------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | Contact Name: Vy Tran | | | Phone: 650/424.5731 | | | Fax: 650/842.5040 | | | Date: 15 November 2010 | | Proprietary Name: | Barcode Conical Collimator Verification (BCCV) | | Classification Name: | Medical charged-particle radiation therapy system
21 CFR 892.5050, Class II
Product Code: IYE | | Common/Usual Name: | Barcode Conical Collimator Verification (BCCV) | | Predicate Devices: | 4D Integrated Treatment Console with PAVS, K081036 | | Device Description: | The Barcode Conical Collimator Verification (BCCV) device provides
verification of conical collimators for the Varian High Energy Clinac
(K100890) and TrueBeam (K092871) devices. Conical collimators are
used during stereotactic radiodurgery (SRS) treatments to deliver small
diameter treatment beams. The BCCV will prevent treatment until the
conical collimator, as required by the treatment plan, has been
scanned. | | Statement of Indications for Use: | The Barcode Conical Collimator Verification device assists operators of
radiation therapy devices by preventing irradiation until the conical | Technological Characteristics: Refer to the Substantial Equivalence Comparison Chart in this dossier. collimator required by the treatment plan is in place. {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002 Ms. Vy Tran Official Correspondent Varian Medical Systems. Inc. 3100 Hansen Way PALO ALTO CA 94304-1038 JAN 1 2 2011 Re: K103394 Trade/Device Name: Barcode Conical Collimator Verification (BCCV) Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: II Product Code: IYE Dated: November 17, 2010 Received: November 19, 2010 Dear Ms. Tran: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 · CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting of {2}------------------------------------------------ medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours. Signature David G. Brown, Ph.D. Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ | | Indications for Use Form | |--|--------------------------| |--|--------------------------| | 510(k) Number (if known): | K103394 | | JAN 12 2011 | |---------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|-------------| | Device Name: | Barcode Conical Collimator Verification (BCCV) | | | | Indications for Use: | The Barcode Conical Collimator Verification device assists operators of radiation therapy devices by preventing irradiation until the conical collimator required by the treatment plan is in place. | | | | Prescription Use |
✓
(Part 21 CFR 801 Subpart D)
| AND/OR | Over-The-Counter Use
(21 CFR 801 Subpart C)
| |------------------|-----------------------------------------------------|--------|--------------------------------------------------------| |------------------|-----------------------------------------------------|--------|--------------------------------------------------------| (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of In Vitro Diagnostics (OIVD) | Division Sign-Off | |--------------------------------------| | Office of In Vitro Diagnostic Device | 0 Evaluation and Safety ﺎﻧﻴﺔ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ ﺍﻟﻤﺘﺤﺪﺓ 510(k) K103394 Page 1 of 1 . --- **Source:** [https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IYE/K103394](https://fda.innolitics.com/submissions/RA/subpart-f%E2%80%94therapeutic-devices/IYE/K103394) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com